| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_709b4a26ef028713f9b302509eb824d7 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5156
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-545 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-001184
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-7155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-715
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 |
| filingDate |
2001-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f165404e503b601042f94498072716f |
| publicationDate |
2001-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-0158479-A1 |
| titleOfInvention |
Immunotherapy using interleukin 13 receptor subunit alpha 2 |
| abstract |
A method for stimulating an immune response against IL-13Rα2 in a subject having or at risk for developing a disease having cells expressing IL-13Rα2 includes the steps of formulating the anti-cancer vaccine outside of the subject and administering the vaccine to the subject in an amount sufficient to stimulate an immune response against IL-13Rα2 in a subject. A compostion for stimulating an immune response against IL-13Rα2 in a subject having or at risk for developing a disease having cells expressing IL-13Rα2 includes an isolated agent that can stimulate immune response against IL-13Rα2. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11472862-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11478538-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018065625-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10434155-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7960361-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10874730-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10485858-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006034334-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0217968-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0217968-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11096996-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7612162-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8859488-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019086676-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8871211-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110022894-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3480212-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10137182-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004087758-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8097256-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10226519-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11723963-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006034334-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1496923-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11478537-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11672847-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11712465-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1496923-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004087758-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7338929-B2 |
| priorityDate |
2000-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |